P C Francis

No ORCID on file · 1 paper in corpus

review 1998

The selective estrogen receptor modulator, raloxifene: an overview of nonclinical pharmacology and reproductive and developmental testing

Reproductive toxicology (Elmsford, N.Y.) ·doi:10.1016/s0890-6238(98)00003-3

Raloxifene is a nonsteroidal, selective estrogen receptor modulator being developed by Eli Lilly and Company as a therapeutic agent for postmenopausal osteoporosis. In the ovariectomized (OVX) rat, raloxifene prevents the loss of bone at th…